The discussion at the AGM is a simple one in my mind. When will AHZ be cashflow positive, what is our strategy to get there. I would also like to know the real plan on the immunotherapy division. The oil and gas sector was in the doldrums a few years ago but those who placed their shares are being richly rewarded now. I suspect that this is a 2020 payday if we can get that far as my view is that this is being rebuilt on solid foundations. Like all shareholders it's good to hear the pathway though and I'm sure many are hurting.
Admedus Trend line, page-51
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.25 |
Change
0.740(5.48%) |
Mkt cap ! $301.2M | |||
| Open | High | Low | Value | Volume |
| $13.60 | $14.25 | $13.35 | $309.6K | 22.39K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1150 | $14.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.25 | 314 | 1 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| AVR (ASX) Chart |